Literature DB >> 12226703

Extended pathogenicity of recombinant polioviruses.

S C Arya1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12226703     DOI： 10.1007/s10096-002-0783-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  7 in total

1.  Multicenter quality assessment of PCR methods for detection of enteroviruses.

Authors:  P Muir; A Ras; P E Klapper; G M Cleator; K Korn; C Aepinus; A Fomsgaard; P Palmer; A Samuelsson; A Tenorio; B Weissbrich; A M van Loon
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Acute disseminated encephalomyelitis associated with poliomyelitis vaccine.

Authors:  H Ozawa; S Noma; Y Yoshida; H Sekine; T Hashimoto
Journal:  Pediatr Neurol       Date:  2000-08       Impact factor: 3.372

3.  In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy.

Authors:  H Bruhn; T Weber; V Thorwirth; J Frahm
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

4.  Neural hearing loss in a child with poliomyelitis: a histopathological study.

Authors:  E Bachor; C S Karmody
Journal:  J Laryngol Otol       Date:  2001-03       Impact factor: 1.469

5.  Cellular localization of poliovirus RNA in the spinal cord during acute paralytic poliomyelitis.

Authors:  S H Isaacson; K Sivakumar; D M Asher; K L Pomeroy; M Ramos-Alvarez; C J Gibbs; D C Gajdusek; M C Dalakas
Journal:  Ann N Y Acad Sci       Date:  1995-05-25       Impact factor: 5.691

6.  Poliomyelitis: hyperintensity of the anterior horn cells on MR images of the spinal cord.

Authors:  M S Malzberg; J M Rogg; C A Tate; V Zayas; J D Easton
Journal:  AJR Am J Roentgenol       Date:  1993-10       Impact factor: 3.959

7.  Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.

Authors:  A Georgopoulou; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-11       Impact factor: 3.267
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.